Dynamic Changes in Circulatory Cytokines and Chemokines Levels in Mild to Severe COVID-19 Patients-Reference-Cited by-同舟云学术

Dynamic Changes in Circulatory Cytokines and Chemokines Levels in Mild to Severe COVID-19 Patients

Published:2023-01-03 Issue:2 Volume:38 Page:212-219
ISSN:0970-1915
Container-title:Indian Journal of Clinical Biochemistry
language:en
Short-container-title:Ind J Clin Biochem

Author:

Tiwari Vandana,Agarwal Jyotsna,Pathak Anumesh Kumar,Singh Shivani

Funder

Indo-U.S. Science & Technology Forum [IUSSTF]

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s12291-022-01108-x.pdf

Reference30 articles.

1. Kumar S, Thambiraja TS, Karuppanan K, Subramaniam G. Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein. J Med Virol. 2022;94(4):1641–9. https://doi.org/10.1002/jmv.27526.

2. Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7(1):1–1.

3. Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, El Jammal T, et al. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev. 2020;19(7):102567. https://doi.org/10.1016/j.autrev.2020.102567.

4. Ye CH, Hsu WL, Peng GR, Yu WC, Lin WC, Hu S, et al. Role of the immune microenvironment in SARS-CoV-2 infection. Cell Transplant. 2021;3(30):09636897211010632.

5. Gómez-Rial J, Rivero-Calle I, Salas A, Martinon-Torres F. Role of monocytes/macrophages in Covid-19 pathogenesis: implications for therapy. Infect Drug Resist. 2020;13:2485. https://doi.org/10.2147/IDR.S258639.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of the donors’ COVID-19 status on the outcomes of allogeneic hematopoietic stem cell transplantation: a multi-center retrospective study;Frontiers in Microbiology;2024-07-15

2. Assessment of the Levels of Interleukin-10, Tumor Necrosis-α, and Interferon-γ in Severe Acute Respiratory Syndrome Coronavirus 2 Infected Patients;Medical Journal of Babylon;2024-06

3. Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study;Frontiers in Immunology;2024-01-04

4. Silent Symptoms, Active Immunity: Insights into Early-Stage Cytokine Expressions in Ugandan Mild and Asymptomatic COVID-19 subjects;2023-11-09

5. Investigation of the relationship between monocyte chemoattractant protein 1 rs1024611 variant and severity of COVID-19;Cytokine;2023-11